Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Helsen Pharma & Consulting from Geel, company number BE0799409266, closed financial year 2025 with a result of € 22,350 after tax. For that financial year Helsen Pharma & Consulting recorded a gross margin of € 36,831 and equity of € 46,294. Compared with financial year 2024, the result moved from € 13,944 to € 22,350. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 46,294
▲ 93% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 22,350
▲ 60% vs 2024
Profit after tax over the fiscal year.
€ 5,154
▼ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 36,294.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 152,406
▼ 11% vs 2024
€ 18,589 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 2,048
▲ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,833
▲ 69% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 34,636 | € 36,831 | ▲ 6% |
| Profit after taxes | € 13,944 | € 22,350 | ▲ 60% |
| Equity | € 23,944 | € 46,294 | ▲ 93% |
| Total debts | € 237,660 | € 223,435 | ▼ 6% |
| Cash | € 8,846 | € 5,154 | ▼ 42% |
| Retained profit | € 13,944 | € 36,294 | ▲ 160% |
| Bank debt | € 170,296 | € 152,406 | ▼ 11% |
| Balance sheet total | € 261,604 | € 269,729 | ▲ 3% |
Key figures of Helsen Pharma & Consulting, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Helsen Pharma & Consulting?
What happened at Helsen Pharma & Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 22,350 (▲ 60% vs 2024). Source: NBB ↗
- New establishment in Geel. KBO
- Start of the company according to the CBE. KBO
- Yannick Helsen became a director. NBB
In short
From € 13,944 profit in 2024 to € 22,350 profit in 2025.
Paid € 11,532 in corporate taxes since 2024.
Best year ever: 2025, with € 22,350 profit.
A new publication or filing at Helsen Pharma & Consulting? We notify you, reason included.
Follow Helsen Pharma & ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Helsen Pharma & Consulting is Yannick Helsen. Yannick Helsen is also behind APOTHEEK PANORAMA THIELS.
Directors
According to the 2025 annual accounts
since 2023
Establishments
Establishment units
Physical locations of this company
Elsum 58
2440 Geel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0799.409.266
- VAT number
- BE 0799.409.266
- Registered office
- Elsum 58, 2440 Geel
- Names & denominations
- Helsen Pharma & Consulting · H P C
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 March 2023
- Peppol
- Active · Active since 18 Nov 2025
- Contact
- apotheekpanoramathiels.be
- Activities · NACE
Vermogensbeheer
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Overige vormen van onderwijs
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering